Cytodyn Inc (CYDY)

[kgromax]

Happy to see you back.

...should show how good leronlimab is ...
...should be VERY impressive for leronlimab...
...should improve...
...to be remove or reduced with leronlmab...
...should have impressive results ...

A healthy dose of facts in a sea of unrealistic expectations:
every previous 50 times a prediction has been made about Leronlimab which "should have" impressive results, it has FAILED to meet any regulator or partner's expectation.

Failures each time, everywhere, in more than 7 countries. The entire last 4 years. The entire last 20 years also.

Consequently, naive investors should apply an extra dose of scepticism.

That's REALITY